Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Allergy Clin Immunol ; 145(4): 1174-1181.e6, 2020 04.
Article in English | MEDLINE | ID: mdl-31954777

ABSTRACT

BACKGROUND: Grass pollen allergy is one of the most common allergies worldwide. OBJECTIVE: The aim of this study was to evaluate the usefulness of grass pollen allergen molecules for prediction of grass pollen allergy during childhood and up to adolescence. METHOD: Questionnaire data and sera obtained from the study subjects at the ages of 4, 8, and 16 years from the population-based Barn/Children Allergy Milieu Stockholm Epidemiology birth cohort were used. Sera from 763 representative subjects with serum samples available at all 3 ages were analyzed for IgE reactivity to 8 Phleum pratense (Phl p) allergens (MeDALL [Mechanisms for the Development of Allergies] chip) and to timothy grass extract (ImmunoCAP). Allergic rhinitis to grass pollen (ARg) was defined as upper airway symptoms during grass pollen exposure. RESULTS: The prevalence of sensitization to any Phl p molecule was higher compared with that to timothy extract at all 3 ages: at the age of 4 years, 9.7% versus 6.8%; at the age of 8 years, 28.4% versus 15.3%; and at the age of 16 years, 37.1% versus 27.1%. General estimating equations analyses revealed that among children sensitized at the age of 4 years, the overall odds ratio (OR) of later ARg (up to 16 years) was increased only for IgE reactivity to Phl p 1 (OR = 4.9) and natural Phl p 4 (OR = 6.9). The likelihood of later symptoms increased with the number of allergen molecules; at the age of 4 years, 2 or more molecules predicted ARg to 78% and 3 or more molecules predicted ARg to 95%. A positive test result for timothy extract predicted ARg to 70%. CONCLUSIONS: Natural Phl p 4 is a hitherto unrecognized early indicator of grass pollen allergy, in addition to Phl p 1. To identify grass pollen sensitization and predict later ARg, allergen molecules are of added value to timothy extract alone and may help clinicians improve prediction of grass pollen allergy.


Subject(s)
Allergens/immunology , Immunoglobulin E/metabolism , Plant Extracts/immunology , Plant Proteins/immunology , Rhinitis, Allergic/diagnosis , Adolescent , Child , Child, Preschool , Cohort Studies , Humans , Immunization , Immunologic Tests , Phleum , Pollen/immunology , Prevalence , Prognosis , Rhinitis, Allergic/epidemiology , Rhinitis, Allergic/immunology , Skin Tests , Surveys and Questionnaires , Sweden/epidemiology
2.
Lakartidningen ; 1142017 03 21.
Article in Swedish | MEDLINE | ID: mdl-28350417

ABSTRACT

Cardiac implantable electronic devices (CIED) not an absolute contraindication to MRI Conventional cardiac implantable electronic devices (CIED) are presently not an absolute contraindication to magnetic resonance imaging (MRI), which thus is accessible for device patients depending on risk/benefit assessments. While current literature suggests that MRI can be performed without risk if precautions are taken, adverse events have been reported. The number of MR conditional CIEDs is rapidly increasing, and depending on device and electrode combinations, patients can now undergo advanced MRI at 3.0 T without risk, possibly with restriction, e.g. anatomy coverage. This article describes published guidelines, recommendations and complications that may appear during MRI and precautions to avoid and manage them. The recommendations made are based on a thorough literature review and our own experiences reported with the aim to increase the awareness of healthcare professionals so that device patients no longer are excluded from the advantages of MRI as a diagnostic tool.


Subject(s)
Defibrillators, Implantable/standards , Magnetic Resonance Imaging , Pacemaker, Artificial/standards , Contraindications , Equipment Safety , Humans , Magnetic Resonance Imaging/adverse effects , Practice Guidelines as Topic , Risk Factors
4.
J Clin Endocrinol Metab ; 97(3): E443-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22259064

ABSTRACT

CONTEXT: There is growing recognition that a large number of individuals living in Western society are chronically sleep deprived. Sleep deprivation is associated with an increase in food consumption and appetite. However, the brain regions that are most susceptible to sleep deprivation-induced changes when processing food stimuli are unknown. OBJECTIVE: Our objective was to examine brain activation after sleep and sleep deprivation in response to images of food. INTERVENTION: Twelve normal-weight male subjects were examined on two sessions in a counterbalanced fashion: after one night of total sleep deprivation and one night of sleep. On the morning after either total sleep deprivation or sleep, neural activation was measured by functional magnetic resonance imaging in a block design alternating between high- and low-calorie food items. Hunger ratings and morning fasting plasma glucose concentrations were assessed before the scan, as were appetite ratings in response to food images after the scan. MAIN OUTCOME MEASURES: Compared with sleep, total sleep deprivation was associated with an increased activation in the right anterior cingulate cortex in response to food images, independent of calorie content and prescan hunger ratings. Relative to the postsleep condition, in the total sleep deprivation condition, the activation in the anterior cingulate cortex evoked by foods correlated positively with postscan subjective appetite ratings. Self-reported hunger after the nocturnal vigil was enhanced, but importantly, no change in fasting plasma glucose concentration was found. CONCLUSIONS: These results provide evidence that acute sleep loss enhances hedonic stimulus processing in the brain underlying the drive to consume food, independent of plasma glucose levels. These findings highlight a potentially important mechanism contributing to the growing levels of obesity in Western society.


Subject(s)
Brain/physiopathology , Food , Hunger/physiology , Reward , Sleep Deprivation/physiopathology , Adult , Appetite/physiology , Brain Mapping , Cross-Over Studies , Humans , Magnetic Resonance Imaging , Male , Photic Stimulation
5.
J Invest Dermatol ; 128(4): 917-25, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17943185

ABSTRACT

Human epidermis elaborates two small cationic, highly hydrophobic antimicrobial peptides (AMP), beta-defensin 2 (hBD2), and the carboxypeptide cleavage product of human cathelicidin (hCAP18), LL-37, which are co-packaged along with lipids within epidermal lamellar bodies (LBs) before their secretion. Because of their colocalization, we hypothesized that AMP and barrier lipid production could be coregulated by altered permeability barrier requirements. mRNA and immunostainable protein levels for mBD3 and cathelin-related antimicrobial peptide (CRAMP) (murine homologues of hBD2 and LL-37, respectively) increase 1-8 hours after acute permeability barrier disruption and normalize by 24 hours, kinetics that mirror the lipid metabolic response to permeability barrier disruption. Artificial permeability barrier restoration, which inhibits the lipid-synthetic response leading to barrier recovery, blocks the increase in AMP mRNA/protein expression, further evidence that AMP expression is linked to permeability barrier function. Conversely, LB-derived AMPs are also important for permeability barrier homeostasis. Despite an apparent increase in mBD3 protein, CRAMP-/- mice delayed permeability barrier recovery, attributable to defective LB contents and abnormalities in the structure of the lamellar membranes that regulate permeability barrier function. These studies demonstrate that (1) the permeability and antimicrobial barriers are coordinately regulated by permeability barrier requirements and (2) CRAMP is required for permeability barrier homeostasis.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Epidermis/metabolism , beta-Defensins/metabolism , Animals , Antimicrobial Cationic Peptides/analysis , Antimicrobial Cationic Peptides/genetics , Cathelicidins , Epidermis/chemistry , Mice , Mice, Knockout , Mice, Mutant Strains , Permeability , Up-Regulation , beta-Defensins/analysis , beta-Defensins/genetics
6.
J Clin Invest ; 117(11): 3339-49, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17975669

ABSTRACT

The skin is the first line of defense against microbial infection, and psychological stress (PS) has been shown to have adverse effects on cutaneous barrier function. Here we show that PS increased the severity of group A Streptococcus pyogenes (GAS) cutaneous skin infection in mice; this was accompanied by increased production of endogenous glucocorticoids (GCs), which inhibited epidermal lipid synthesis and decreased lamellar body (LB) secretion. LBs encapsulate antimicrobial peptides (AMPs), and PS or systemic or topical GC administration downregulated epidermal expression of murine AMPs cathelin-related AMP and beta-defensin 3. Pharmacological blockade of the stress hormone corticotrophin-releasing factor or of peripheral GC action, as well as topical administration of physiologic lipids, normalized epidermal AMP levels and delivery to LBs and decreased the severity of GAS infection during PS. Our results show that PS decreases the levels of 2 key AMPs in the epidermis and their delivery into LBs and that this is attributable to increased endogenous GC production. These data suggest that GC blockade and/or topical lipid administration could normalize cutaneous antimicrobial defense during PS or GC increase. We believe this to be the first mechanistic link between PS and increased susceptibility to infection by microbial pathogens.


Subject(s)
Anti-Bacterial Agents/metabolism , Antimicrobial Cationic Peptides/metabolism , Epidermis/metabolism , Skin Diseases, Infectious/metabolism , Streptococcal Infections/metabolism , Streptococcus pyogenes , Stress, Psychological , Animals , Antimicrobial Cationic Peptides/genetics , Clobetasol/administration & dosage , Clobetasol/metabolism , Disease Susceptibility , Down-Regulation , Epidermis/chemistry , Epidermis/microbiology , Female , Glucocorticoids/administration & dosage , Glucocorticoids/metabolism , Humans , Lipid Metabolism , Mice , Mice, Nude , Skin Diseases, Infectious/pathology , Streptococcal Infections/pathology
7.
J Invest Dermatol ; 127(8): 1973-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17392835

ABSTRACT

Hailey-Hailey disease (HHD) (MIM 16960) is an autosomal-dominant blistering skin disease caused by a mutation in the Ca2+-ATPase ATP2C1 (protein SPCA1), responsible for controlling Ca2+ concentrations in the cytoplasm and Golgi in human keratinocytes. Cytosolic Ca2+ concentrations, in turn, play a major role in the regulation of keratinocyte differentiation. To study how ATP2C1 function impacts keratinocyte differentiation, we assessed involucrin expression in HHD keratinocytes. Involucrin is a protein that makes up the cornified envelope of keratinocytes and is expressed in response to increased intracellular Ca2+ concentrations. Even though HHD keratinocytes suffer from abnormally high cytosolic Ca2+, we found that these cells expressed lower involucrin protein levels at both low and high extracellular Ca2+ concentrations when compared with normal control keratinocytes. Decreased involucrin protein levels were caused by lower involucrin mRNA levels in HHD keratinocytes. Decreased involucrin mRNA, in turn, was caused by increased rates of involucrin mRNA degradation. Ca2+-sensitive involucrin AP-1 promotor activity was increased, both in HHD keratinocytes and in an small interfering RNA (siRNA) experimental model, suggesting compensatory promoter upregulation in the face of increased mRNA degradation. This report provides new insights into differentiation defects in HHD and its relationship to Ca2+ signaling.


Subject(s)
Keratinocytes/metabolism , Pemphigus, Benign Familial/metabolism , Protein Precursors/genetics , RNA, Messenger/metabolism , Calcium/metabolism , Calcium Signaling , Calcium-Transporting ATPases/physiology , Cells, Cultured , Humans , Promoter Regions, Genetic , Protein Precursors/analysis , RNA, Small Interfering/pharmacology
8.
J Cell Sci ; 119(Pt 4): 671-9, 2006 Feb 15.
Article in English | MEDLINE | ID: mdl-16467572

ABSTRACT

Keratinocyte differentiation, adhesion and motility are directed by extracellular Ca2+ concentration increases, which in turn increase intracellular Ca2+ levels. Normal keratinocytes, in contrast to most non-excitable cells, require Ca2+ release from both Golgi and endoplasmic reticulum Ca2+ stores for efficient Ca2+ signaling. Dysfunction of the Golgi human secretory pathway Ca2+-ATPase hSPCA1, encoded by ATP2C1, abrogates Ca2+ signaling and causes the acantholytic genodermatosis, Hailey-Hailey disease. We have examined the role of the endoplasmic reticulum Ca2+ store, established and maintained by the sarcoplasmic and endoplasmic reticulum Ca2+-ATPase SERCA2 encoded by ATP2A2, in Ca2+ signaling. Although previous studies have shown acute SERCA2 inactivation to abrogate Ca2+ signaling, we find that chronic inactivation of ATP2A2 in keratinocytes from patients with the similar acantholytic genodermatosis, Darier disease, does not impair the response to raised extracellular Ca2+ levels. This normal response is due to a compensatory upregulation of hSPCA1, as inactivating ATP2C1 expression with siRNA blocks the response to raised extracellular Ca2+ concentrations in both normal and Darier keratinocytes. ATP2C1 inactivation also diminishes Darier disease keratinocyte viability, suggesting that compensatory ATP2C1 upregulation maintains viability and partially compensates for defective endoplasmic reticulum Ca2+-ATPase in Darier disease keratinocytes. Keratinocytes thus are unique among mammalian cells in their ability to use the Golgi Ca2+ store to mediate Ca2+ signaling.


Subject(s)
Calcium Signaling , Calcium-Transporting ATPases/metabolism , Darier Disease/metabolism , Animals , Calcium Signaling/genetics , Calcium-Transporting ATPases/genetics , Cell Survival/genetics , Cells, Cultured , Darier Disease/pathology , Down-Regulation , Gene Expression Regulation, Enzymologic , Golgi Apparatus/metabolism , Humans , Keratinocytes/metabolism , Keratinocytes/pathology , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...